Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;94(3):220-226.
doi: 10.1097/QAI.0000000000003272.

PrEP Use and HIV Incidence Among Youth At-Risk for HIV Infection in Los Angeles and New Orleans: Findings From ATN 149

Anu Aryal  1 , Arleen A Leibowitz  2 , Warren Scott Comulada  1   3 , Mary Jane Rotheram-Borus  3 , Robert Bolan  4 , Manuel A Ocasio  5 , Dallas Swendeman  1   3 ; ATN CARES Study Team
Affiliations

PrEP Use and HIV Incidence Among Youth At-Risk for HIV Infection in Los Angeles and New Orleans: Findings From ATN 149

Anu Aryal et al. J Acquir Immune Defic Syndr. .

Abstract

Introduction: Expanding HIV pre-exposure prophylaxis (PrEP) use is key to goals for lowering new HIV infections in the U.S. by 90% between 2022 and 2030. Unfortunately, youth aged 16-24 have the lowest PrEP use of any age group and the highest HIV incidence rates.

Methods: To examine the relationship between HIV seroconversion and PrEP uptake, adherence, and continuity, we used survival analysis and multivariable logistic regression on data of 895 youth at-risk for HIV infection enrolled in Adolescent Trials Network for HIV Medicine protocol 149 in Los Angeles and New Orleans, assessed at 4-month intervals over 24 months.

Results: The sample was diverse in race/ethnicity (40% Black, 28% Latine, 20% White). Most participants (79%) were cis-gender gay/bisexual male but also included 7% transgender female and 14% trans masculine and nonbinary youth. Self-reported weekly PrEP adherence was high (98%). Twenty-seven participants acquired HIV during the study. HIV incidence among PrEP users (3.12 per 100 person year [PY]) was higher than those who never used PrEP (2.53/100 PY). The seroconversion incidence was highest among PrEP users with discontinuous use (3.36/100 PY). If oral PrEP users were adherent using 2-monthly long-acting injectables, our estimate suggests 2.06 infections per 100 PY could be averted.

Conclusions: Discontinuous use of PrEP may increase risk of HIV acquisition among youth at higher risk for HIV infection and indications for PrEP. Thus, to realize the promise of PrEP in reducing new HIV infections, reducing clinical burdens for PrEP continuation are warranted.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by

References

    1. Fauci AS, Redfield RR, Sigounas G, et al. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321:844–845. - PubMed
    1. National HIV/AIDS Strategy (2022–2025). The White House. Washington, DC; 2021. Available at: https://www.hiv.gov/federal-response/national-hiv-aids-strategy/national.... Accessed December 19, 2022.
    1. Ending the HIV Epidemic in the U.S. (EHE). Division of HIV Prevention, Centers for Disease Prevention and Control (CDC). 2022. Available at: https://www.cdc.gov/endhiv/index.html. Accessed December 19, 2022.
    1. Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV epidemic initiative (preliminary data): National HIV Surveillance System data reported through June 2021; and pre-exposure prophylaxis (PrEP) data reported through March 2021. HIV Surveill Data Tables. 2021;2:2. Available at: https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-2-n.... Accessed December 19, 2022.
    1. HIV by Age: HIV Risk Behaviors. Centers for Disease Control and Prevention (CDC). 2022. Available at: https://www.cdc.gov/hiv/group/age/risk-behaviors.html. Accessed December 19, 2022.

Publication types

Substances